Marie Hudson

Research Scientist, Rheumatology MD, MPH, FRCPC



  • Clinician-scientist, Jewish General Hospital and Lady Davis Institute
  • Associate Professor, Department of Medicine, McGill University


Research Interests

  • Systemic autoimmune rheumatic diseases


Dr. Hudson received her MD from McGill University, where she completed her residency training in internal medicine and rheumatology. She subsequently obtained a Master’s degree in Public Health from Columbia University in New York, and then returned to McGill to pursue a post-doctoral fellowship in epidemiology. Dr. Hudson is a fellow of the Royal College of Physicians and Surgeons of Canada and has received the prestigious New Investigator Award from the Canadian Institutes of Health Research.

Learn more

Dr. Hudson pursues research in systemic autoimmune rheumatic diseases. In particular, she is one of the founding members of the Canadian Scleroderma Research Group (CSRG), a CIHR-funded, multi-centre group of researchers that follows a cohort of over 1600 SSc patients across Canada. She has published landmark studies documenting the magnitude of impairment in health-related quality of life (HRQoL) with scleroderma. She is particularly interested in scleroderma lung disease, its natural history, its optimal treatment, and its impact on HRQoL. She is currently developing a novel translational and clinical research program focused on cellular therapies for SSc. Dr Hudson is also involved in a number of studies in other rheumatic diseases, including inflammatory myositis, rheumatoid arthritis and rheumatic-immune related adverse events resulting from cancer immunotherapy. 

She is the recipient of the 2011 Canadian Rheumatology Association Young Investigator Award.